Viewing Study NCT01307059


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2025-12-25 @ 1:02 PM
Study NCT ID: NCT01307059
Status: COMPLETED
Last Update Posted: 2017-12-26
First Post: 2011-03-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Sweden
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module